- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02340299
Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2
Nasal High Frequency Oscillation Ventilation Versus Nasal Continuous Positive Airway Pressure to Reduce Post-extubation pCO2 in Very Low Birth Weight Infants: a Randomized Controlled Trial
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Randomized controlled clinical trial comparing nHFOV vs nCPAP immediately after extubation of VLBW infants.
Intervention and treatment protocol as described for the two study arms.
Definition of treatment failure (infant meets at least one criterion):
- Sustained pCO2 >80 mmHg and pH <7.20 confirmed by arterial or capillary blood gas analysis in spite of optimized non-invasive respiratory support with maximum settings as defined above.
- Fraction of inspired oxygen (FiO2) >0.6 to maintain peripheral oxygen saturation as measured by pulse oximetry (SpO2) at 90-94% in spite of optimized non-invasive respiratory support with maximum settings as defined above.
- Reintubation (study patients may be intubated at any time, due to clinical considerations, with or without reaching another criterion of "treatment failure").
Sample size:
Assuming a variability of the paCO2 as previously reported for difficult-to-wean preterm infants in our unit (Czernik C, J Matern Fetal Neonatal Med 2012) and a treatment failure rate of 22% within 72 hours after extubation, we calculated a sample size of 34 patients in each study arm to detect a difference in the paCO2 of 7 mmHg, using a two-sided significance of 0.05 and a power of 0.8.
Randomization:
Sequence generation by an independent statistician and a study nurse. Block randomization using at least two different block sizes. Allocation concealment using sequentially numbered opaque sealed envelopes.
Data monitoring:
By an independent statistician.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Berlin, Tyskland
- Dpt. of Neonatology, Charité - Universitätsmedizin Berlin
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Gestational age <32+0 weeks
- Birth weight <1500 g
- Received mechanical ventilation via an endotracheal tube for ≥120 h
- Caffeine treatment according to unit guidelines
- paCO2 <65 mmHg with pH >7.2
- FiO2 25-40% to maintain SpO2 at 90-94%.
- Time-cycled, pressure-controlled ventilation: PIP ≤22 cm H2O, PEEP ≤6 cm H2O; Volume guarantee ventilation: Working Ppeak ≤22 cm H2O, PEEP ≤6 cm H2O; High frequency oscillation ventilation: Pmean ≤12 cm H2O, Amplitude ≤30 cm H2O
- Decision of the attending clinician to extubate
Exclusion Criteria:
- Major congenital malformation requiring surgery
- Duct-dependent congenital heart disease
- Neuromuscular disease
- Participation in another randomized controlled trial
- Death before reaching the eligibility criteria
- Hydrocortisone treatment at the time of enrolment
- Chronological age >28 days
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: nHFOV
Immediately after extubation, nHFOV is provided via binasal prongs. Ventilator settings: Frequency set at 10 Hz, I:E ratio 33:66, amplitude 20 cm H2O, Pmean 8 cm H2O, flow 7 l/min. Set FiO2 to maintain SpO2 at 90-94%. The weaning process is left to the discretion of the attending physician. Maximum amplitude 30 cm H2O, minimum frequency 9 Hz, maximum Pmean 8 cm H2O. For infants in the nHFOV-group who "fail" nHFOV (see definition below), but do not need immediate reintubation, a non-invasive "Rescue-Treatment" may be provided. The decision to attempt "Rescue-Treatment", the mode of respiratory support and the ventilator settings used are at the discretion of the attending clinician. |
Extubation to ventilator-derived nHFOV using binasal prongs
|
Aktiv komparator: nCPAP
Immediately after extubation, nCPAP is provided via binasal prongs. Ventilator settings: CPAP level set at 8 cm H2O, flow 7 l/min. Set FiO2 to maintain SpO2 at 90-94%. The weaning process is left to the discretion of the attending physician. Maximum CPAP level 8 cm H2O, maximum flow 8 l/min. For infants in the nCPAP-group who "fail" nCPAP (see definition below), but do not need immediate reintubation, "Rescue-nHFOV" via binasal prongs may be provided. The decision to attempt "Rescue-nHFOV" and the ventilator settings used are at the discretion of the attending clinician. |
Extubation to ventilator-derived nCPAP using binasal prongs
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
paCO2 at 72 h After Extubation
Tidsramme: 64 h to 80 h
|
Partial pressure of arterial carbon dioxide assessed between 64 and 80 hours, and on average 72 hours.
|
64 h to 80 h
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
pH at 2 h After Extubation
Tidsramme: within the first 6 h after extubation
|
within the first 6 h after extubation
|
|
paO2 at 2 h After Extubation
Tidsramme: within the first 6 h after extubation
|
within the first 6 h after extubation
|
|
paCO2 at 2 h After Extubation
Tidsramme: within the first 6 h after extubation
|
within the first 6 h after extubation
|
|
Base Excess at 2 h After Extubation
Tidsramme: within the first 6 h after extubation
|
within the first 6 h after extubation
|
|
pH at 72 h After Extubation
Tidsramme: 64-80 h after extubation
|
64-80 h after extubation
|
|
paO2 at 72 h After Extubation
Tidsramme: 64-80 h after extubation
|
64-80 h after extubation
|
|
Base Excess at 72 h After Extubation
Tidsramme: 64-80 h after extubation
|
64-80 h after extubation
|
|
Successful Extubation
Tidsramme: 72 h after extubation
|
Defined as the number of patients breathing spontaneously in their assigned treatment group for ≥72h without reaching the criterion of "treatment failure"
|
72 h after extubation
|
Treatment Failure
Tidsramme: within 7 days after extubation
|
Defined as the number of patients reaching the criterion of "treatment failure"
|
within 7 days after extubation
|
Reintubation
Tidsramme: within 7 days after extubation
|
Defined as the number of patients being reintubated
|
within 7 days after extubation
|
Highly Viscous Secretions
Tidsramme: within 72 hours after extubation
|
Defined as the documented number of episodes of airway obstruction due to highly viscous secretions per patient
|
within 72 hours after extubation
|
Other Adverse Effects
Tidsramme: until discharge
|
Incidences of the following adverse effects: Intraventricular hemorrhage III°-IV° (Papile), surgical necrotizing enterocolitis, pneumothorax, pulmonary interstitial emphysema, persistent ductus arteriosus requiring surgical closure, retinopathy of prematurity requiring laser treatment and/or injection of bevacizumab, death or moderate to severe bronchopulmonary dysplasia (Jobe) at 36 weeks' gestational age, periventricular leukomalacia
|
until discharge
|
Duration of Respiratory Support
Tidsramme: until discharge
|
Total duration of mechanical ventilation, total duration of supplemental oxygen, number of infants discharged with home oxygen
|
until discharge
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
pH at 2 h After Switch to "Rescue Treatment"
Tidsramme: within the first 6 h after switch to "rescue treatment"
|
within the first 6 h after switch to "rescue treatment"
|
|
paO2 at 2 h After Switch to "Rescue Treatment"
Tidsramme: within the first 6 h after switch to "rescue treatment"
|
within the first 6 h after switch to "rescue treatment"
|
|
paCO2 at 2 h After Switch to "Rescue Treatment"
Tidsramme: within the first 6 h after switch to "rescue treatment"
|
within the first 6 h after switch to "rescue treatment"
|
|
Base Excess at 2 h After Switch to "Rescue Treatment"
Tidsramme: within the first 6 h after switch to "rescue treatment"
|
within the first 6 h after switch to "rescue treatment"
|
|
Successful Rescue
Tidsramme: 72 h after switch to "rescue" treatment
|
Defined as spontaneous breathing for ≥72h after starting "rescue" therapy, without reaching the criterion of "treatment failure"
|
72 h after switch to "rescue" treatment
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Christoph Czernik, MD PhD, Charite University, Berlin, Germany
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- EA2/011/12
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Sykdommer i luftveiene
-
Federal University of Rio Grande do SulRekruttering
-
Majmaah UniversityHar ikke rekruttert ennåSinus Tract | Enkeltbesøk | Multibesøk | Enkel kjegle obturasjonsteknikk | Biokeramisk forsegler
-
Maastricht University Medical CenterWingate Institute of NeurogastroenterologyRekrutteringfMRI | Transkutan vagus nervestimulering (tVNS) | Nucleus of the Solitary Tract (NTS)Nederland, Storbritannia
-
Damascus HospitalTilbaketrukketHelicobacter Pylori gastrointestinal tract infeksjonDen syriske arabiske republikk
-
Damascus HospitalUNIPHARMA. Universal Pharmaceutical Industries; Ibn Alhaytham Pharma. Industries...UkjentHelicobacter Pylori gastrointestinal tract infeksjonDen syriske arabiske republikk
-
University of LjubljanaScience and Research Centre KoperFullførtFysisk form | Fysisk undersøkelse | Aerob kapasitet | Cardio Respiratory Fitness | KampberedskapSlovenia
-
The Hospital for Sick ChildrenFullførtEvaluering av HomeCare RN Respiratory EducationCanada
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National...RekrutteringInfluensa | Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Alvorlig Akutt Respiratorisk Syndrom Coronavirus (SARS-CoV)Forente stater, Australia, Spania, Danmark, Hellas, Argentina, Storbritannia, Belgia, Chile, Tyskland, Peru, Thailand
-
University Hospital, BrestFullført
-
Zhang JianhengFullførtState Key Laboratory of Respiratory DiseaseKina
Kliniske studier på nHFOV
-
Alexandria UniversityFullførtHemodynamisk ustabilitet | Ekkokardiografi | Ventilator Lung; NyfødtEgypt
-
Daping Hospital and the Research Institute of Surgery...FullførtRespiratorisk distress syndrom | Premature spedbarnKina
-
Jiulongpo No.1 People's HospitalUkjentPremature spedbarnKina
-
University of ManitobaSuspendert
-
Fondazione Poliambulanza Istituto OspedalieroFondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione... og andre samarbeidspartnereFullførtFor tidlig fødsel | Respiratorisk distress syndromItalia, Litauen
-
The Hospital for Sick ChildrenFullført
-
Xingwang ZhuUniversity of Southern California; Children's Hospital of Fudan University og andre samarbeidspartnereFullførtPremature spedbarnKina
-
Daping Hospital and the Research Institute of Surgery...RekrutteringNasal høyfrekvent oscillasjonsventilasjonKina
-
Daping Hospital and the Research Institute of Surgery...The First Affiliated Hospital of Anhui Medical University; LanZhou University og andre samarbeidspartnereFullførtIntuberte spedbarn var tiltenkt ekstubering ved bruk av ikke-invasive ventilasjonsstrategierKina
-
Gao WeiWeiUkjent